Anna Somuyiwa
Head of the Centre for Innovation in Regulatory Science
Anna has over 19 years’ experience in Regulatory Affairs, having worked with various pharmaceutical companies and Clinical Research Organizations.
She is responsible for the Centre for Innovation in Regulatory Science (CIRS), a neutral, independent UK-based subsidiary of Clarivate plc. Her responsibilities include setting and delivering the research strategy with CIRS members, stakeholders, and CIRS staff.
Latest news
Clarivate Presents Cortellis Regulatory AI Assistant to Cut Through Complexity in Safety and Compliance
Powered by agentic AI, new features help regulatory teams improve accuracy and enable faster, more confident decisions across the product lifecycle London, U.K. — December 4, 2025 — Clarivate Plc…
Clarivate and the Chinese Academy of Sciences Release the 2025 Research Fronts Report
Annual report identifies 110 hot and 18 emerging Research Fronts London, U.K. December 3, 2025. Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, and the Chinese Academy…
Clarivate Reveals Global Shifts in Research Collaboration
New report explores multilateral partnerships, Mainland China’s rising influence, and strategic challenges for the U.S. London, U.K. December 2, 2025: Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence,…